NL8801826A - Werkwijze voor het detecteren van mutaties in markergenen. - Google Patents

Werkwijze voor het detecteren van mutaties in markergenen. Download PDF

Info

Publication number: NL8801826A
Authority: NL; Netherlands
Prior art keywords: vector; dna; cells; fragments; host
Prior art date: 1988-07-19

Application number

NL8801826A

Other languages

English (en)

Dutch (nl)

Original Assignee

Tno

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-07-19

Filing date

1988-07-19

Publication date

1990-02-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19852648&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL8801826(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1988-07-19 Application filed by Tno filed Critical Tno

1988-07-19 Priority to NL8801826A priority Critical patent/NL8801826A/nl

1989-07-18 Priority to EP89201895A priority patent/EP0353812B1/fr

1989-07-18 Priority to EP95201753A priority patent/EP0683238A3/fr

1989-07-18 Priority to AT93200367T priority patent/ATE132529T1/de

1989-07-18 Priority to EP93200367A priority patent/EP0548056B2/fr

1989-07-18 Priority to ES89201895T priority patent/ES2061943T3/es

1989-07-18 Priority to AT89201895T priority patent/ATE100151T1/de

1989-07-18 Priority to DE68925369T priority patent/DE68925369T3/de

1989-07-18 Priority to ES93200367T priority patent/ES2081679T3/es

1989-07-18 Priority to DE68912228T priority patent/DE68912228T2/de

1989-07-18 Priority to JP1187193A priority patent/JPH0829093B2/ja

1990-02-16 Publication of NL8801826A publication Critical patent/NL8801826A/nl

1993-01-29 Priority to US08/013,198 priority patent/US5470706A/en

1996-02-07 Priority to GR960400333T priority patent/GR3018927T3/el

Links

238000000034 method Methods 0.000 title claims abstract description 25
230000035772 mutation Effects 0.000 title claims description 29
108090000623 proteins and genes Proteins 0.000 title claims description 24
239000003550 marker Substances 0.000 title claims description 13
230000001580 bacterial effect Effects 0.000 claims abstract description 19
239000013600 plasmid vector Substances 0.000 claims abstract description 8
241000644323 Escherichia coli C Species 0.000 claims abstract description 5
239000013598 vector Substances 0.000 claims description 127
238000004806 packaging method and process Methods 0.000 claims description 40
239000012634 fragment Substances 0.000 claims description 35
210000004027 cell Anatomy 0.000 claims description 26
239000000284 extract Substances 0.000 claims description 21
108091008146 restriction endonucleases Proteins 0.000 claims description 19
241000588724 Escherichia coli Species 0.000 claims description 18
210000004962 mammalian cell Anatomy 0.000 claims description 14
230000009261 transgenic effect Effects 0.000 claims description 13
241000701959 Escherichia virus Lambda Species 0.000 claims description 12
238000003776 cleavage reaction Methods 0.000 claims description 12
230000007017 scission Effects 0.000 claims description 12
241000124008 Mammalia Species 0.000 claims description 11
238000000338 in vitro Methods 0.000 claims description 7
239000013612 plasmid Substances 0.000 claims description 5
239000013602 bacteriophage vector Substances 0.000 claims description 4
230000014509 gene expression Effects 0.000 claims description 3
239000013601 cosmid vector Substances 0.000 claims description 2
230000002950 deficient Effects 0.000 claims description 2
238000013467 fragmentation Methods 0.000 claims description 2
238000006062 fragmentation reaction Methods 0.000 claims description 2
238000006798 ring closing metathesis reaction Methods 0.000 claims description 2
238000010367 cloning Methods 0.000 abstract description 5
108091028043 Nucleic acid sequence Proteins 0.000 abstract 3
241000699666 Mus <mouse, genus> Species 0.000 description 27
101150066555 lacZ gene Proteins 0.000 description 26
238000011830 transgenic mouse model Methods 0.000 description 25
239000000126 substance Substances 0.000 description 23
241000894006 Bacteria Species 0.000 description 18
210000000056 organ Anatomy 0.000 description 16
238000012360 testing method Methods 0.000 description 15
241001465754 Metazoa Species 0.000 description 12
241000699660 Mus musculus Species 0.000 description 12
238000002474 experimental method Methods 0.000 description 11
239000013611 chromosomal DNA Substances 0.000 description 10
230000036438 mutation frequency Effects 0.000 description 8
108090000790 Enzymes Proteins 0.000 description 7
102000004190 Enzymes Human genes 0.000 description 7
FUSGACRLAFQQRL-UHFFFAOYSA-N N-Ethyl-N-nitrosourea Chemical compound CCN(N=O)C(N)=O FUSGACRLAFQQRL-UHFFFAOYSA-N 0.000 description 7
230000000711 cancerogenic effect Effects 0.000 description 7
229940088598 enzyme Drugs 0.000 description 7
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
210000004185 liver Anatomy 0.000 description 6
241000699670 Mus sp. Species 0.000 description 5
230000006378 damage Effects 0.000 description 5
206010007269 Carcinogenicity Diseases 0.000 description 4
108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 4
206010028980 Neoplasm Diseases 0.000 description 4
210000004556 brain Anatomy 0.000 description 4
231100000357 carcinogen Toxicity 0.000 description 4
231100000315 carcinogenic Toxicity 0.000 description 4
239000003183 carcinogenic agent Substances 0.000 description 4
231100000260 carcinogenicity Toxicity 0.000 description 4
230000007670 carcinogenicity Effects 0.000 description 4
238000005352 clarification Methods 0.000 description 4
239000001963 growth medium Substances 0.000 description 4
230000010354 integration Effects 0.000 description 4
239000000463 material Substances 0.000 description 4
230000001681 protective effect Effects 0.000 description 4
OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 3
238000010953 Ames test Methods 0.000 description 3
231100000039 Ames test Toxicity 0.000 description 3
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
102000018251 Hypoxanthine Phosphoribosyltransferase Human genes 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
238000000211 autoradiogram Methods 0.000 description 3
201000011510 cancer Diseases 0.000 description 3
238000001727 in vivo Methods 0.000 description 3
230000011987 methylation Effects 0.000 description 3
238000007069 methylation reaction Methods 0.000 description 3
231100000350 mutagenesis Toxicity 0.000 description 3
231100000219 mutagenic Toxicity 0.000 description 3
230000003505 mutagenic effect Effects 0.000 description 3
238000000746 purification Methods 0.000 description 3
238000011084 recovery Methods 0.000 description 3
239000000523 sample Substances 0.000 description 3
239000000243 solution Substances 0.000 description 3
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
108010077805 Bacterial Proteins Proteins 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
238000002105 Southern blotting Methods 0.000 description 2
102000019197 Superoxide Dismutase Human genes 0.000 description 2
108010012715 Superoxide dismutase Proteins 0.000 description 2
239000007984 Tris EDTA buffer Substances 0.000 description 2
238000013459 approach Methods 0.000 description 2
210000004958 brain cell Anatomy 0.000 description 2
230000002759 chromosomal effect Effects 0.000 description 2
235000005911 diet Nutrition 0.000 description 2
239000003814 drug Substances 0.000 description 2
230000002349 favourable effect Effects 0.000 description 2
238000001502 gel electrophoresis Methods 0.000 description 2
210000004602 germ cell Anatomy 0.000 description 2
230000002779 inactivation Effects 0.000 description 2
238000002955 isolation Methods 0.000 description 2
238000005259 measurement Methods 0.000 description 2
238000000520 microinjection Methods 0.000 description 2
238000002156 mixing Methods 0.000 description 2
238000010172 mouse model Methods 0.000 description 2
230000008520 organization Effects 0.000 description 2
238000007747 plating Methods 0.000 description 2
SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
230000005855 radiation Effects 0.000 description 2
230000002269 spontaneous effect Effects 0.000 description 2
229940032362 superoxide dismutase Drugs 0.000 description 2
WYWHKKSPHMUBEB-UHFFFAOYSA-N tioguanine Chemical compound N1C(N)=NC(=S)C2=C1N=CN2 WYWHKKSPHMUBEB-UHFFFAOYSA-N 0.000 description 2
238000001890 transfection Methods 0.000 description 2
NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 description 1
108700003860 Bacterial Genes Proteins 0.000 description 1
208000003174 Brain Neoplasms Diseases 0.000 description 1
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
230000005778 DNA damage Effects 0.000 description 1
231100000277 DNA damage Toxicity 0.000 description 1
108010067770 Endopeptidase K Proteins 0.000 description 1
208000026350 Inborn Genetic disease Diseases 0.000 description 1
UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
208000024556 Mendelian disease Diseases 0.000 description 1
206010035148 Plague Diseases 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
208000000453 Skin Neoplasms Diseases 0.000 description 1
239000008051 TBE buffer Substances 0.000 description 1
229930003268 Vitamin C Natural products 0.000 description 1
241000607479 Yersinia pestis Species 0.000 description 1
230000002411 adverse Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
102000005936 beta-Galactosidase Human genes 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
230000037396 body weight Effects 0.000 description 1
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
239000004327 boric acid Substances 0.000 description 1
239000002775 capsule Substances 0.000 description 1
231100000504 carcinogenesis Toxicity 0.000 description 1
150000001746 carotenes Chemical class 0.000 description 1
235000005473 carotenes Nutrition 0.000 description 1
230000008859 change Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical group NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 1
230000007123 defense Effects 0.000 description 1
230000037213 diet Effects 0.000 description 1
230000000378 dietary effect Effects 0.000 description 1
229940079593 drug Drugs 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
238000000605 extraction Methods 0.000 description 1
101150045500 galK gene Proteins 0.000 description 1
230000008821 health effect Effects 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
230000002101 lytic effect Effects 0.000 description 1
239000002609 medium Substances 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
231100000150 mutagenicity / genotoxicity testing Toxicity 0.000 description 1
230000010309 neoplastic transformation Effects 0.000 description 1
210000000653 nervous system Anatomy 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
235000011056 potassium acetate Nutrition 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
238000009877 rendering Methods 0.000 description 1
230000008439 repair process Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
238000012216 screening Methods 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000012031 short term test Methods 0.000 description 1
201000000849 skin cancer Diseases 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
238000010186 staining Methods 0.000 description 1
239000000758 substrate Substances 0.000 description 1
108010040614 terminase Proteins 0.000 description 1
229960003087 tioguanine Drugs 0.000 description 1
NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
235000019154 vitamin C Nutrition 0.000 description 1
239000011718 vitamin C Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/73—Expression systems using phage (lambda) regulatory sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Plant Pathology (AREA)
Analytical Chemistry (AREA)
Immunology (AREA)
Crystallography & Structural Chemistry (AREA)
Virology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Enzymes And Modification Thereof (AREA)

NL8801826A 1988-07-19 1988-07-19 Werkwijze voor het detecteren van mutaties in markergenen. NL8801826A (nl)

Priority Applications (13)

Application Number	Priority Date	Filing Date	Title
NL8801826A NL8801826A (nl)	1988-07-19	1988-07-19	Werkwijze voor het detecteren van mutaties in markergenen.
JP1187193A JPH0829093B2 (ja)	1988-07-19	1989-07-18	Ｄｎａをレスキューする方法およびマーカー遺伝子における変異を検出する方法
AT89201895T ATE100151T1 (de)	1988-07-19	1989-07-18	Verfahren fuer die rettung von dns und fuer den nachweis von mutationen in markiergenen.
EP95201753A EP0683238A3 (fr)	1988-07-19	1989-07-18	Procédé pour declonage d'ADN
AT93200367T ATE132529T1 (de)	1988-07-19	1989-07-18	Klonierung von methylierter dns in einem bakteriellen wirtsstamm der zur wirtsrestriktion unfähig ist
EP93200367A EP0548056B2 (fr)	1988-07-19	1989-07-18	Processus pour le clonage d'ADN méthylée dans une souche bactérienne hôte qui est incapable de restriction
ES89201895T ES2061943T3 (es)	1988-07-19	1989-07-18	Un procedimiento para el rescate de adn y para detectar mutaciones en genes marcadores.
EP89201895A EP0353812B1 (fr)	1988-07-19	1989-07-18	Processus pour le sauvetage d'ADN et pour détection des mutations dans des gènes marqueurs
DE68925369T DE68925369T3 (de)	1988-07-19	1989-07-18	Klonierung von methylierter DNS in einem bakteriellen Wirtsstamm der zur Wirtsrestriktion unfähig ist
ES93200367T ES2081679T3 (es)	1988-07-19	1989-07-18	Un procedimiento para clonar dna metilado en un huesped bacteriano incapaz de restriccion por el huesped.
DE68912228T DE68912228T2 (de)	1988-07-19	1989-07-18	Verfahren für die Rettung von DNS und für den Nachweis von Mutationen in Markiergenen.
US08/013,198 US5470706A (en)	1988-07-19	1993-01-29	Process for the rescue of DNA and for detecting mutations in marker genes
GR960400333T GR3018927T3 (en)	1988-07-19	1996-02-07	A process for cloning methylated DNA in a bacterial host incapable of host restriction

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
NL8801826A NL8801826A (nl)	1988-07-19	1988-07-19	Werkwijze voor het detecteren van mutaties in markergenen.
NL8801826		1988-07-19

Publications (1)

Publication Number	Publication Date
NL8801826A true NL8801826A (nl)	1990-02-16

Family

ID=19852648

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL8801826A NL8801826A (nl)	1988-07-19	1988-07-19	Werkwijze voor het detecteren van mutaties in markergenen.

Country Status (8)

Country	Link
US (1)	US5470706A (fr)
EP (3)	EP0548056B2 (fr)
JP (1)	JPH0829093B2 (fr)
AT (2)	ATE132529T1 (fr)
DE (2)	DE68912228T2 (fr)
ES (2)	ES2081679T3 (fr)
GR (1)	GR3018927T3 (fr)
NL (1)	NL8801826A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6307121B1 (en)	1998-05-31	2001-10-23	The University Of Georgia Research Foundation, Inc.	Bacteriophage-based transgenic fish for mutation detection
US6472583B1 (en)	1998-10-26	2002-10-29	The University Of Georgia Research Foundation, Inc.	Plasmid-based mutation detection system in transgenic fish

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL9100567A (nl) *	1991-04-02	1992-11-02	Ingeny Bv	Werkwijze voor het detecteren van mutaties, transgeen zoogdier, transgene zoogdiercel, en werkwijze voor het onderzoeken van stoffen of omstandigheden op mutagene eigenschappen.
EP0671955A4 (fr) *	1992-02-14	1997-04-09	Stratagene Inc	Test de mutagenese utilisant des animaux non humains transgeniques portant des sequences d'adn test.
AU4220093A (en) *	1992-04-27	1993-11-29	Indiana University Foundation	Live animal mutagenesis systems for testing mutagenic agents in vivo
WO1994017208A1 (fr) *	1993-01-21	1994-08-04	President And Fellows Of Harvard College	Methodes et trousses de diagnostic faisant appel aux promoteurs de stress des mammiferes pour determiner la toxicite d'un compose
GB9924973D0 (en) *	1999-10-21	1999-12-22	Cobra Therapeutics Ltd	Preparation of cellular components that are substantially free of chromosomal DNA
CZ20033143A3 (en) *	2001-05-21	2004-04-14	Aclara Biosciences, Inc.	Methods and compositions for analyzing proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4753874A (en) *	1985-07-08	1988-06-28	Board Of Trustees Of The Leland Stanford Junior University	Rapid mutation testing system for human cells
EP0289121B1 (fr) *	1987-05-01	1995-12-27	Stratagene	Test de mutagénèse utilisant des êtres non humains transgéniques porteurs des séquences d'ADN à essayer

1988
- 1988-07-19 NL NL8801826A patent/NL8801826A/nl not_active Application Discontinuation
1989
- 1989-07-18 JP JP1187193A patent/JPH0829093B2/ja not_active Expired - Lifetime
- 1989-07-18 EP EP93200367A patent/EP0548056B2/fr not_active Expired - Lifetime
- 1989-07-18 ES ES93200367T patent/ES2081679T3/es not_active Expired - Lifetime
- 1989-07-18 AT AT93200367T patent/ATE132529T1/de not_active IP Right Cessation
- 1989-07-18 AT AT89201895T patent/ATE100151T1/de not_active IP Right Cessation
- 1989-07-18 EP EP89201895A patent/EP0353812B1/fr not_active Expired - Lifetime
- 1989-07-18 ES ES89201895T patent/ES2061943T3/es not_active Expired - Lifetime
- 1989-07-18 EP EP95201753A patent/EP0683238A3/fr not_active Withdrawn
- 1989-07-18 DE DE68912228T patent/DE68912228T2/de not_active Expired - Lifetime
- 1989-07-18 DE DE68925369T patent/DE68925369T3/de not_active Expired - Lifetime
1993
- 1993-01-29 US US08/013,198 patent/US5470706A/en not_active Expired - Lifetime
1996
- 1996-02-07 GR GR960400333T patent/GR3018927T3/el unknown

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6307121B1 (en)	1998-05-31	2001-10-23	The University Of Georgia Research Foundation, Inc.	Bacteriophage-based transgenic fish for mutation detection
US6472583B1 (en)	1998-10-26	2002-10-29	The University Of Georgia Research Foundation, Inc.	Plasmid-based mutation detection system in transgenic fish

Also Published As

Publication number	Publication date
DE68925369D1 (de)	1996-02-15
ATE132529T1 (de)	1996-01-15
JPH0829093B2 (ja)	1996-03-27
US5470706A (en)	1995-11-28
EP0353812A2 (fr)	1990-02-07
DE68912228D1 (de)	1994-02-24
DE68912228T2 (de)	1994-08-04
ES2081679T3 (es)	1996-03-16
GR3018927T3 (en)	1996-05-31
EP0548056B2 (fr)	2001-04-04
EP0353812B1 (fr)	1994-01-12
ES2061943T3 (es)	1994-12-16
EP0548056A1 (fr)	1993-06-23
ATE100151T1 (de)	1994-01-15
EP0683238A3 (fr)	1995-12-20
EP0353812A3 (en)	1990-03-07
EP0683238A2 (fr)	1995-11-22
DE68925369T3 (de)	2001-08-09
EP0548056B1 (fr)	1996-01-03
JPH02142471A (ja)	1990-05-31
DE68925369T2 (de)	1996-05-15

Legal Events

Date	Code	Title	Description
1990-02-16	A1B	A search report has been drawn up
1991-03-01	BV	The patent application has lapsed

Publication	Publication Date	Title
Reed et al.	1995	Molecular cytogenetic analysis of the double-CMA3 chromosome of lake trout, Salvelinus namaycush
Carrasco et al.	1999	Evidence for the presence of sex chromosomes in the Nile tilapia (Oreochromis niloticus) from synaptonemal complex analysis of XX, XY and YY genotypes
Saintigny et al.	1999	Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint
Matsuda et al.	1989	X-ray-and mitomycin C (MMC)-induced chromosome aberrations in spermiogenic germ cells and the repair capacity of mouse eggs for the X-ray and MMC damage
EP0548056B2 (fr)	2001-04-04	Processus pour le clonage d'ADN méthylée dans une souche bactérienne hôte qui est incapable de restriction
Joshi et al.	1990	Stage-dependent variation in the radiosensitivity of DNA in developing male germ cells
Miller	1970	Autoradiography in human cytogenetics
Zakharov et al.	1982	Genetic determination of NOR activity in human lymphocytes from twins
Kohn et al.	1982	Influence of ataxia telangiectasia gene dosage on bleomycin-induced chromosome breakage and inhibition of replication in human lymphoblastoid cell lines
Schmid et al.	2003	Chromosome banding in AmphibiaXXVIII. Homomorphic XY sex chromosomes and a derived Y-autosome translocation in Eleutherodactylus riveroi (Anura, Leptodactylidae)
de Almeida-Toledo et al.	1995	Chromosomal location of NORs and C bands in F1 hybrids of bighead carp and silver carp reared in Brazil
Matsuda et al.	1989	Mechanism of chromosome aberration induction in the mouse egg fertilized with sperm recovered from postmeiotic germ cells treated with methyl methanesulfonate
Spofford et al.	1991	Nucleolus organizer-suppressed position-effect variegation in Drosophila melanogaster
PC et al.	1997	A ZZ/ZW Sex Chromosome System in lmparfinis mirini (Pisces, Siluriformes)
Borodin et al.	1990	Synapsis in single and double heterozygotes for partially overlapping inversions in chromosome 1 of the house mouse
Bertsche	1985	Micronucleus induction in mammalian cell cultures treated with ionizing radiations
Vlak et al.	1975	Studies on the mechanism of replication of adenovirus DNA: IV. Discontinuous DNA chain propagation
Wojcik et al.	2005	Rad51C-deficient CL-V4B cells exhibit normal levels of mitomycin C-induced SCEs but reduced levels of UVC-induced SCEs
Fogle	1990	Role of cytogenetics for breeding management of squirrel monkey colonies
Liebetrau et al.	1997	Exploring the role of oxygen in Fanconi’s anemia
Ashley et al.	1990	Correlation between meiotic behavior and breakpoints with respect to G-bands in two X-4 mouse translocations: T (X; 4) 7R1 and T (X; 4) 8R1
Breneman et al.	1996	Activity banding of human chromosomes as shown by histone acetylation
Röscheisen et al.	1994	Characterization of spontaneous and induced mutations in SV40-transformed normal and ataxia telangiectasia cell lines
Simon et al.	1993	Newly acquired peri-telomeric heterochromatin in a transgenic mouse lineage
Krishnaja et al.	2000	Quinacrine dihydrochloride, the non-surgical female sterilant induces dicentrics, rings, and marker chromosomes in human peripheral blood lymphocytes treated in vitro: a preliminary report

NL8801826A - Werkwijze voor het detecteren van mutaties in markergenen. - Google Patents

Info

Links

Classifications

Landscapes

Priority Applications (13)

Applications Claiming Priority (2)

Publications (1)

Family

ID=19852648

Family Applications (1)

Country Status (8)

Cited By (2)

Families Citing this family (6)

Family Cites Families (2)

Cited By (2)

Also Published As

Similar Documents

Legal Events